文献速递脑血管病外科神经重症

脑脊液中巨噬细胞CD163表达与蛛网膜下腔出血结局的关联

Macrophage CD163 expression in cerebrospinal fluid: association with subarachnoid hemorrhage outcome.
PubMed 文献 · J Neurosurg · 2018-07-20

该研究在发病第1天用流式细胞术和共聚焦显微镜检测21例蛛网膜下腔出血(SAH)患者与28例未破裂动脉瘤对照者的脑脊液巨噬细胞CD163表达。结果显示SAH患者CD163表达显著高于对照(p<0.001),改良Fisher分级(β=0.407,p=0.005)和脑脊液胆红素浓度(β=0.311,p=0.015)与CD163表达独立正相关,CD163表达与1个月神经功能结局呈反向关联(p=0.003)。

要点

  • SAH患者脑脊液巨噬细胞CD163表达较未破裂动脉瘤对照显著升高(p<0.001)。
  • 校正年龄和性别后,改良Fisher分级(β=0.407,p=0.005)与脑脊液胆红素浓度(β=0.311,p=0.015)与CD163表达独立正相关。
  • 按改良Fisher分级匹配后,CD163表达与1个月神经功能结局呈反向关联(p=0.003)。

核心结论

  • 这项早期研究提示,流式细胞术检测的脑脊液巨噬细胞CD163表达与结局呈反向关联,可能具有一定神经保护功能,并为SAH后神经炎症过程提供了独特见解。

研究设计与样本

  • 研究纳入21例SAH患者和28例未破裂动脉瘤患者(对照),于发病第1天用流式细胞术和共聚焦显微镜分析脑脊液巨噬细胞CD163表达。
  • 采用线性回归和匹配病例对照分析评估CD163表达与改良Fisher分级或改良Rankin量表评分的关联。

主要发现

  • SAH患者脑脊液巨噬细胞CD163表达较对照显著升高(p<0.001)。
  • 校正年龄和性别后,改良Fisher分级(β=0.407,p=0.005)和脑脊液胆红素浓度(β=0.311,p=0.015)与脑脊液巨噬细胞CD163表达呈独立正相关。
  • 高改良Fisher分级SAH患者的脑脊液巨噬细胞中CD163与糖蛋白A(CD235a,红细胞标记物)共定位增加,低改良Fisher分级SAH患者较少,对照者无共定位。
  • 按改良Fisher分级匹配SAH患者后,脑脊液巨噬细胞CD163表达与1个月神经功能结局呈反向关联(p=0.003)。

关键数值与推荐

  • SAH患者与对照的脑脊液巨噬细胞CD163表达比较:p<0.001。
  • 改良Fisher分级与CD163表达的回归系数β=0.407,p=0.005。
  • 脑脊液胆红素浓度与CD163表达的回归系数β=0.311,p=0.015。
  • CD163表达与1个月神经功能结局的关联:p=0.003。

临床怎么用

  • 作者认为,流式细胞术检测的脑脊液巨噬细胞CD163表达与结局呈反向关联,可能具有神经保护功能,并为SAH后神经炎症过程提供了独特见解。

局限性

  • 原文称本研究为早期研究(This early study)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Even though heme-induced cerebral inflammation contributes to many of the adverse sequelae seen in patients with subarachnoid hemorrhage (SAH), little is known about the mechanism; mouse models have shown a critical role for macrophages/microglia. Macrophage CD163 is a hemoglobin scavenger receptor involved in blood clearance after SAH. The authors hypothesized that the modified Fisher score is independently associated with cerebrospinal fluid (CSF) macrophage CD163 expression on postictal day 1, and that CSF macrophage CD163 expression is associated with 1-month neurological outcome. METHODS: CSF macrophages from 21 SAH and 28 unruptured aneurysm patients (control) were analyzed for CD163 expression using flow cytometry and confocal microscopy on postictal day 1. Significant associations with modified Fisher scale grades or modified Rankin Scale scores were determined using linear regression and a matched case control analysis. RESULTS: CSF macrophage CD163 expression was significantly increased in SAH patients compared with controls (p < 0.001). The modified Fisher scale (mF) grades (β = 0.407, p = 0.005) and CSF bilirubin concentrations (β = 0.311, p = 0.015) were positively and independently associated with CSF macrophage CD163 expression when the analysis was controlled for age and sex. CSF macrophages from an SAH patient with a high mF grade had increased co-localization of CD163 and glycophorin A (CD235a, an erythrocyte marker) compared with those from an SAH patient with a low mF grade. The controls had no co-localization. CSF macrophage CD163 expression (p = 0.003) was inversely associated with 1-month neurological outcome, when SAH patients were matched based on mF grade. CONCLUSIONS: This early study suggests that CSF macrophage CD163 expression, as measured by flow cytometry, may have some neuroprotective function given its inverse association with outcome and provides unique insights into the neuroinflammatory process after SAH.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Thomas AJ, Ogilvy CS, Griessenauer CJ, et al. Macrophage CD163 expression in cerebrospinal fluid: association with subarachnoid hemorrhage outcome. J Neurosurg. 2018. PMID: 30028262. doi:10.3171/2018.2.JNS172828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。